Israel Active

The Edmond and Lily Safra Children’s Hospital just inaugurated at Israel’s Sheba Medical Center, features unique early genetic tests for detecting and treating rare diseases. It will also treat children from the Palestinian Authority, Gaza, the UAE, Bahrain, and Morocco.

For the first time ever, experts from Israel’s Sheba Medical Center, including doctors, nurses, and simulation specialists, helped prepare Kenya’s navy for mass casualty scenarios. They worked alongside military and civilian personnel from Kenya, the US 5th fleet, Qatar, and Denmark.

UAE’s MBZUAI has signed an agreement with Israel’s Quris-AI (see previously) to establish a world-class Bio-AI center in Abu Dhabi, that will support development of personalized medications, specifically tailored to the MENA (Middle East Nort Africa) region population.

The Hebrew University of Jerusalem and the University of Kentucky have received a joint $1 million grant to study new aspects of RNA biology. They will try to discover why humans have more complex brains than other organisms with roughly the same number of genes?

Israel’s Magen David Adom and America’s Hatzolah Air are partnering to provide any future emergency medical evacuations in Israel. MDA’s flight paramedics will board Hatzolah Air and MDA Medevac helicopters to perform rescues via MDA’s Tiberias and Beer Sheva air bases.

AI technology from Israel’s Buildots (see previously) is constructing the new maternity, pediatrics, emergency, and critical care center at Royal Bournemouth Hospital. It is the first UK healthcare facility to be built using Artificial Intelligent tech to increase efficiency and decrease costs.

The Hebrew University-Hadassah School of Dental Medicine is establishing the Robert I. Schattner Oral Health Center for People with Disabilities. The state-of-the-art facility will provide accessible, optimal care for patients and specialized training for dental professionals.

Tel Aviv University researchers have identified two genomic proteins LHX2 and OTX2 that affect the chances of contracting Age-related Macular Degeneration (AMD). The discovery is a key stage in understanding the genetic mechanisms related to AMD and other complex genetic diseases.

Israel’s Minovia Therapeutics (see previously) is testing mitochondria augmentation therapy (MAT) on children with rare, untreatable mitochondrial diseases. It has had some success with Pearson’s Disease sufferers. It may eventually also be able to treat age-related diseases.

The AI digital biopsy from Israel’s Imagene (see previously) not only identifies if someone has cancer but also what mutation is responsible for the anomaly. This is something pathologists cannot determine using a microscope. With results in minutes, not weeks.